Taiwan · Delayed Price · Currency is TWD General Biologicals Statistics
Total Valuation
TPEX:4117 has a market cap or net worth of TWD 654.83 million. The enterprise value is 2.58 billion.
| Market Cap | 654.83M |
| Enterprise Value | 2.58B |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:4117 has 70.79 million shares outstanding. The number of shares has increased by 13.39% in one year.
| Current Share Class | 70.79M |
| Shares Outstanding | 70.79M |
| Shares Change (YoY) | +13.39% |
| Shares Change (QoQ) | +7.59% |
| Owned by Insiders (%) | 7.91% |
| Owned by Institutions (%) | 1.41% |
| Float | 45.36M |
Valuation Ratios
The trailing PE ratio is 1.21.
| PE Ratio | 1.21 |
| Forward PE | n/a |
| PS Ratio | 2.52 |
| PB Ratio | 0.82 |
| P/TBV Ratio | 0.87 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 4.98 |
| EV / Sales | 9.93 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.57, with a Debt / Equity ratio of 3.17.
| Current Ratio | 1.57 |
| Quick Ratio | 1.39 |
| Debt / Equity | 3.17 |
| Debt / EBITDA | n/a |
| Debt / FCF | -29.09 |
| Interest Coverage | -2.94 |
Financial Efficiency
Return on equity (ROE) is 108.50% and return on invested capital (ROIC) is -4.72%.
| Return on Equity (ROE) | 108.50% |
| Return on Assets (ROA) | -2.08% |
| Return on Invested Capital (ROIC) | -4.72% |
| Return on Capital Employed (ROCE) | -3.22% |
| Weighted Average Cost of Capital (WACC) | 2.89% |
| Revenue Per Employee | 3.21M |
| Profits Per Employee | 6.41M |
| Employee Count | 81 |
| Asset Turnover | 0.06 |
| Inventory Turnover | 2.67 |
Taxes
In the past 12 months, TPEX:4117 has paid 44.24 million in taxes.
| Income Tax | 44.24M |
| Effective Tax Rate | 7.87% |
Stock Price Statistics
The stock price has decreased by -41.24% in the last 52 weeks. The beta is 0.57, so TPEX:4117's price volatility has been lower than the market average.
| Beta (5Y) | 0.57 |
| 52-Week Price Change | -41.24% |
| 50-Day Moving Average | 10.18 |
| 200-Day Moving Average | 12.73 |
| Relative Strength Index (RSI) | 41.98 |
| Average Volume (20 Days) | 121,149 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:4117 had revenue of TWD 260.23 million and earned 518.98 million in profits. Earnings per share was 7.64.
| Revenue | 260.23M |
| Gross Profit | 92.14M |
| Operating Income | -139.62M |
| Pretax Income | 562.41M |
| Net Income | 518.98M |
| EBITDA | -56.87M |
| EBIT | -139.62M |
| Earnings Per Share (EPS) | 7.64 |
Balance Sheet
The company has 604.26 million in cash and 2.53 billion in debt, with a net cash position of -1.93 billion or -27.22 per share.
| Cash & Cash Equivalents | 604.26M |
| Total Debt | 2.53B |
| Net Cash | -1.93B |
| Net Cash Per Share | -27.22 |
| Equity (Book Value) | 798.26M |
| Book Value Per Share | 11.25 |
| Working Capital | 285.73M |
Cash Flow
In the last 12 months, operating cash flow was -77.27 million and capital expenditures -9.74 million, giving a free cash flow of -87.01 million.
| Operating Cash Flow | -77.27M |
| Capital Expenditures | -9.74M |
| Depreciation & Amortization | 82.75M |
| Net Borrowing | -7.81M |
| Free Cash Flow | -87.01M |
| FCF Per Share | -1.23 |
Margins
Gross margin is 35.41%, with operating and profit margins of -53.65% and 199.43%.
| Gross Margin | 35.41% |
| Operating Margin | -53.65% |
| Pretax Margin | 216.12% |
| Profit Margin | 199.43% |
| EBITDA Margin | -21.85% |
| EBIT Margin | -53.65% |
| FCF Margin | n/a |
Dividends & Yields
TPEX:4117 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -13.39% |
| Shareholder Yield | -13.39% |
| Earnings Yield | 79.25% |
| FCF Yield | -13.29% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TPEX:4117 has an Altman Z-Score of 0.15 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.15 |
| Piotroski F-Score | 4 |